tiprankstipranks

Christopher Peetz Insider Profile

11 Followers
Christopher Peetz, CEO, Director at Mirum Pharmaceuticals, holds 381.81K shares in Mirum Pharmaceuticals (Ticker: MIRM), holds 191.81K shares in Arcutis Biotherapeutics (Ticker: ARQT), holds 0.00 shares in Tobira Therapeutics (Ticker: TBRA).
tipranks
Christopher Peetz

Christopher Peetz
Mirum Pharmaceuticals (MIRM)
CEO, Director

Ranked #98,607 out of 108,575 Corporate Insiders

Profitable Transactions

42%
5 out of 12 Profitable Transactions

Average Return

-25.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$42M
88.43%
11.57%
A breakdown of Christopher Peetz's holdings

Insider Roles

Mirum Pharmaceuticals
(MIRM)
CEO, Director
Arcutis Biotherapeutics
(ARQT)
Director
Roles that Christopher Peetz holds in companies

Most Profitable Insider Trade

Stock:
Mirum Pharmaceuticals
(MIRM)
Rating:Informative Buy
Date:Sep 10, 2019 - Sep 10, 2020
Return:+91.90%
The most profitable trade made by Christopher Peetz

Christopher Peetz's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Mirum Pharmaceuticals
Aug 11, 2026
CEO, Director
Uninformative Buy
58.60K
$36.77M
Arcutis Biotherapeutics
Jul 17, 2026
Director
Uninformative Buy
$4.81M
TBRA
Tobira Therapeutics
$0.00
ALPN
Alpine Immune Sciences
May 20, 2024
Uninformative Sell
$0.00
List of latest transactions for each holding click on a transaction to see Christopher Peetz's performance on stock

Christopher Peetz insider profile FAQ

What is the percentage of profitable transactions made by Christopher Peetz?
The percentage of profitable transactions made by Christopher Peetz is 42%.
    What is the average return per transaction made by Christopher Peetz?
    The average return per transaction made by Christopher Peetz is -25.50%.
      What stocks does Christopher Peetz hold?
      Christopher Peetz holds: MIRM, ARQT, TBRA, ALPN stocks.
        What was Christopher Peetz’s latest transaction?
        Christopher Peetz latest transaction was an Uninformative Buy of $58.60K.
          What was Christopher Peetz's most profitable transaction?
          Christopher Peetz’s most profitable transaction was an Informative Buy of MIRM stock on September 10, 2019. The return on the trade was 91.90%.
            What is Christopher Peetz's role in Mirum Pharmaceuticals?
            Christopher Peetz's role in Mirum Pharmaceuticals is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.